Schistosoma mansoni in mice: The pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response

Scandinavian Journal of Immunology

Volumn 51, Issue 3, 2000, Pages 237-243

  Farah, I O ^a   Johansson, M ^b   Lovgren Bengtson K ^b   Hau, J ^c  

^a INSTITUTE OF PRIMATE RESEARCH   (Kenya)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 5; PRAZIQUANTEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GRANULOMATOSIS; HELPER CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFECTION; SCHISTOSOMA MANSONI; SPLEEN CELL; SUPERINFECTION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CELLS, CULTURED; CONCANAVALIN A; CULTURE MEDIA; CYTOKINES; FEMALE; GRANULOMA; LIVER DISEASES, PARASITIC; MICE; MICE, INBRED BALB C; PRAZIQUANTEL; RECURRENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0034103498     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00667.x     Document Type: Article

References (34)

1. World Health Organization. WHO Fact Sheet, May 1996, pp. 115. Geneva: WHO, 1996.
2. Andrade ZA. Pathology of human schistosomiasis. Mem Inst Oswaldo Cruz 1987;82:17-23.
3. Mathews RC, Boros DL. Anti L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen induced IL-2 production in Schistosoma mansoni infection. Infect Immun 1986;54:820-6.
4. Mossmann TR, Coffman RL. TH-1 and TH-2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
5. Jankovic D, Wynn TA, Kullberg MC et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B-cell and IFN gamma dependent effector mechanisms. J Immunol 1999; 162:345-51.
6. Wynn TA, Cheever AW. Cytokine regulation of granuloma formation in schistosomiasis. Curr Opin Immunol 1995;7:505-11.
7. Wynn TA, Eltoum I, Cheever AW, Lewis F, Gause W, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by the eggs of S. mansoni. J Immunol 1993;151: 1430-40.
8. Grzych JM, Pearce EJ, Cheever AW et al. Egg deposition is the major stimulus for the production of Th2 cytokines in murine Schistosomiasis mansoni. J Immunol 1991;146:1322-7.
9. Lukacs NW, Boros DL. Lymphokine regulation of granuloma formation in murine Schislosomiasis mansoni. Clin Immunol Immunopathol 1993;68:57-63.
10. Jankovic D, Kullberg MC, Dombrowicz D et al. Fc epsilonRl-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology J Immunol 1997;159:1868-75.
11. Boros D. The role of cytokines in the formation of the schistosome egg granuloma. Immunobiology 1994;191:441-50.
12. Bogen SA, Flores-Villanueva PO, McCusker ME et al. In situ analysis of cytokine responses in experimental murine schistosomiasis. Lab Invest 1995;73:252-8.
13. Wilson RA, Coulson PS. Why don't we have a schistosomiasis vaccine? Parasitol Today 1998;14:97-9.
14. Bergquist NR. Schistosomiasis vaccine development: Approaches and prospects. Mem Inst Oswaldo Cruz 1995;90:221-7.
15. Capron M, Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science 1994;264:1876-7.
16. Wilson RA. Interferon gamma is a key cytokine in lung phase immunity to schistosomes but what is the precise role? Braz J Med Biol Res 1998;31:157-61.
17. Capron A. Schistosomiasis. Forty years' war on the worm. Parasitol Today 1998;14:379-84.
18. Cioli D. Chemotherapy of schistosomiasis: An update. Parasitol Today 1998;14:418-22.
19. Stelma FF, Talla I, Sow S et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995;53:167-70.
20. Butterworth AE, Curry AJ, Dunne DW et al. Immunity and morbidity in human Schistosomiasis mansoni. Trop Geogr Med 1994;46:197-208.
21. Savioli L, Renganathan E, Montresor A, Davis A, Behbehani K. Control of schistosomiasis - A global picture. Parasitol Today 1997; 13:444-8.
22. Coelho PMZ, Toppa NH, Feldman JS, Goncalves R, Mello RT. Schistosoma mansoni: Permanence of modulation of the granulomatous inflammatory response in mice cured in the chronic phase. Int J Parasitol 1996;26:1393-5.
23. Hassan SI, Botros SS, el-Nahal HM et al. Effect of specific chemotherapy on the immune response and resistance to reinfection in experimental Schistosomiasis mansoni. Int J Immunopharmacol 1990;12:207-15.
24. Nyindo M, Kariuki TM, Mola PW et al. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect Immun 1999;67: 636-42.
25. Caulada-Benedetti Z, al-Zamel F, Sher A, James S. Comparison of Thl- and Th2- Associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991;46: 655-60.
26. Sher A, Coffman RL, Hieny S, Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990;145:3911-6.
27. Smythies LE, Coulson PS, Wilson RA. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 1992;149:3654-8.
28. Silvia-Teixeira DN, Doughty BL, Goes AM. Human schistosomiasis modulation of in vitro granulomatous hypersensitivity and lymphocyte proliferative response by macrophages undergoing differentiation. Scand J Immunol 1996;44:522-9.
29. Bosshardt SC, Freeman GL Jr, Secor WE, Colley DG. IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/ J mice infected with Schistosoma mansoni. Parasite Immunol 1997;19:347-53.
30. Wynn TA, Cheever AW, Williams ME et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down modulation of chronic disease. J Immunol 1998;160:4473-80.
31. Roberts M, Butterworth AE, Kimani G et al. Immunity after treatment of human schistosomiasis: Association between cellular responses and resistance to reinfection. Infect Immun 1993;61: 4984-93.
32. Dunne DW, Webster M, Smith P et al. The isolation of a 22kDa band after SDS-PAGE of Schistosoma mansoni adult worms and its use to demonstrate that IgE responses against the antigen(s) it contains are associated with human resistance to reinfection. Parasitol Immunol 1997;19:79-89.
33. King CL, Xianli J, Malhotra J et al. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansani. J Immunol 1997;158:294-300.
34. Boros LD, Whitfield JR. Enhanced Thl and dampened th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine Schistosomiasis mansoni. Infect Immun 1999; 67:1187-93.